Rchr
J-GLOBAL ID:201601005518785805   Update date: Aug. 05, 2021

Fukagawa Satoshi

フカガワ サトシ | Fukagawa Satoshi
Affiliation and department:
Papers (7):
  • URUSHIYAMA Daichi, FUKAGAWA Satoshi, HIRAKAWA Toyofumi, YOSHIKAWA Ken-Ichi, IZUCHI Daisuke, MIYATA Kohei, KURAKAZU Masamitsu, YOTSUMOTO Fusanori, HIROMATSU Kenji, OTA Eiji, et al. MiR-4535 and MiR-1915-5p in Amniotic Fluid as Predictive Biomarkers for Chorioamnionitis. Future Science OA. 2021
  • MIYAMOTO Shingo, IZUCHI Daisuke, FUKAGAWA Satoshi, YOTSUMOTO Fusanori, YOSHIKAWA Ken-Ichi, KIYOSHIMA Chihiro, NAN Son-U, MIYATA Kohei, ITO Tomohiro, KURAKAZU Masamitsu, et al. Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer. Anticancer Res. 2018. 38. 4347-4351
  • Kohei Miyata, Fusanori Yotsumoto, Satoshi Fukagawa, Chihiro Kiyoshima, Nam Sung Ouk, Daichi Urushiyama, Tomohiro Ito, Takahiro Katsuda, Masamitsu Kurakazu, Ryota Araki, et al. Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer. ANTICANCER RESEARCH. 2017. 37. 7. 3955-3960
  • Satoshi Fukagawa, Fusanori Yotsumoto, Takashi Odawara, Sadao Manabe, Toyokazu Ishikawa, Shin'Ichiro Yasunaga, Shingo Miyamoto. Antitumour Effects of Intravenous Administration of BK-UM, a Novel Inhibitor of HB-EGF, in Ovarian Cancer Therapy. ANTICANCER RESEARCH. 2017. 37. 7. 3891-3896
  • Fusanori Yotsumoto, Satoshi Fukagawa, Kohei Miyata, Sung Ouk Nam, Takahiro Katsuda, Daisuke Miyahara, Takashi Odawara, Sadao Manabe, Toyokazu Ishikawa, Shin'ichiro Yasunaga, et al. HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFR(T790M). ANTICANCER RESEARCH. 2017. 37. 7. 3825-3831
more...
Professional career (1):
  • 学士(医学) (ー)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page